Pharmanovia Competitors and Similar CompaniesClear all

Pharmanovia's competitors and similar companies include Akorn, Mundipharma, Shenzhen Salubris Pharmaceutical and CCL.

	Pharmanovia Pharmanovia (formerly known as Atnahs Pharma) is a specialty pharmaceutical company focusing on acquiring branded medicines and specialty pharma companies and developing its own niche medicines.	Akorn Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.	Mundipharma Mundipharma is a global network of independent associated companies focused on the development of medicines.	Shenzhen Salubris Pharmaceutical Shenzhen Salubris Pharmaceutical (深圳信立泰药业股份有限公司) is a pharmaceutical company that develops and supplies drugs.	CCL CCL is a manufacturer and distributor of healthcare products.
Founding Date	Founding Date 2013	Founding Date 1948	Founding Date 1952	Founding Date 1998	Founding Date 1965
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Basildon, GB HQ Barangaroo, AU København, DK Vadodara, IN Milano, IT Breda, NL see more	Locations Lake Forest, US HQ Gurugram, IN Jawalpur, IN Jersey, JE Hettlingen, CH Amityville, US Ann Arbor, US see more	Locations Cambridge, GB HQ Wien, AT Mechelen, BE Sofia, BG Markham, CA Dali, CY see more	Locations Shenzhen, CN HQ	Locations Lahore, PK HQ
Employees	Employees 3442% decrease	Employees 2,2272% increase	Employees 2,112	Employees 3,596	Employees 2,0251% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 12 m	Valuation ($) N/A	Valuation ($) 5 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $682.4m (FY, 2019)	Revenue (est.) N/A	Revenue (est.) ¥4.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $429.7m (FY, 2019)	Cost of goods N/A	Cost of goods ¥1.1b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $252.7m (FY, 2019)	Gross profit N/A	Gross profit ¥3.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($226.8m) (FY, 2019)	Net income N/A	Net income ¥652.8m (FY, 2025)	Net income N/A

For sources of this data, please see the company profile

View Company Profiles

Akorn

Lake Forest, US

Employees

2,227↑ 2% increase

Akorn is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.

View company

Mundipharma

Cambridge, GB

Employees

2,112

Mundipharma is a global network of independent associated companies focused on the development of medicines.

View company

Shenzhen Salubris Pharmaceutical

Shenzhen, CN

Employees

3,596

Shenzhen Salubris Pharmaceutical (深圳信立泰药业股份有限公司) is a pharmaceutical company that develops and supplies drugs.